The trademark application XUPERIS was filed by Veriton Pharma Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on May 22, 2022, and it was registered by office on August 29, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 23, 2022. Appointment and Replacement of representative of the trademark registration was recorded on December 4, 2022.